![Pharma Equity Group – Opdatering på 2. kvartal 2024](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/f5b1119e-c5b5-471a-b7eb-9b5f5692944d.png)
Pharma Equity Group
0.297 DKK -1%HC Andersen Capital receives payment from Pharma Equity Group for a DigitalIR/Corporate Visibility agreement. See disclaimer.
12 investors are following this company
Pharma Equity Group develops new medicines for the local treatment of serious and life-threatening inflammatory diseases for which there is currently no adequate treatment. The company uses repositioning of existing drugs and brings drug candidates to a clinical phase III stage, after which it is handed over to a strategic partner who will complete the development of the products and bring them to market, either independently or in collaboration with the company.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NASDAQ Copenhagen
PEG
Daily low / high price
0.288 / 0.3
DKK
Market cap
303.82M DKK
Turnover
56.69K DKK
Volume
192K
Latest research
Extensive report
Inderes' extensive report is an investor's handbook on customer companies covered by our research.
The latest extensive report was released
Read the reportAnalyst
![Claus Thestrup Claus Thestrup](https://www.inderes.se/cdn-cgi/image/format=auto,width=128,height=128,quality=90,fit=cover/https://content.inderes.se/assets/637ef734-dcbf-426c-bf91-0ac4a79aa71e.png)
Claus Thestrup
CEO, Sweden
Latest videos
Financial calendar
Interim report
16.08.2024
Interim report
15.11.2024
ShowingAll content types
![Pharma Equity Group – Opdatering på 2. kvartal 2024](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/f5b1119e-c5b5-471a-b7eb-9b5f5692944d.png)
![HCA Capital: Wrap up from 2024 Life Science seminar](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=contain/https://content.inderes.se/assets/ab49c0b1-56d0-4e1c-b729-6c79c89b7be2.png)
HCA Capital: Wrap up from 2024 Life Science seminar
![Life Science seminar 2024](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/ab49c0b1-56d0-4e1c-b729-6c79c89b7be2.png)
Life Science seminar 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Results of extraordinary general meeting in Pharma Equity Group A/S
Forløb af ekstraordinær generalforsamling i Pharma Equity Group A/S
![Dagens aktienyheder 3/6: RTX A/S, Asetek, Ascelia Pharma AB, Pharma Equity Group A/S, Gubra og ExpreS2ion Biotech](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=contain/https://content.inderes.se/assets/8e35221b-ab03-4e96-85e7-32c5d1f6cfe4.png)
Dagens aktienyheder 3/6: RTX A/S, Asetek, Ascelia Pharma AB, Pharma Equity Group A/S, Gubra og ExpreS2ion Biotech
![Pharma Equity Group: Colorektal Cancer & Polypper](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/e63e4a03-8498-4f91-be79-24be09bcc666.png)
Pharma Equity Group: Colorektal Cancer & Polypper
![Pharma Equity Group: Investors appreciate eventful, and mostly positive, 1. quarter 2024](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=contain/https://content.inderes.se/assets/e63e4a03-8498-4f91-be79-24be09bcc666.png)
Pharma Equity Group: Investors appreciate eventful, and mostly positive, 1. quarter 2024
Bestyrelsens beslutning om udstedelse af konvertible lån
The Board of Director's decision to issue convertible loans
![Pharma Equity Group – Opdatering på 1. Kvartal 2024](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/f5b1119e-c5b5-471a-b7eb-9b5f5692944d.png)
Pharma Equity Group – Opdatering på 1. Kvartal 2024
![Dagens aktienyheder 16/05: Ascelia Pharma, Expres2ion Biotechnologies, Nordic Solar, Pharma Equity Group](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=contain/https://content.inderes.se/assets/c21580e9-17e8-470c-b245-33c782a3e9c8.png)
Dagens aktienyheder 16/05: Ascelia Pharma, Expres2ion Biotechnologies, Nordic Solar, Pharma Equity Group
Consolidated interim report 1 January – 31 March 2024
Konsolideret delårsrapport 1. januar – 31. marts 2024
Afsøgning af muligheder angående en rettet kapitalforhøjelse til markedskurs i Pharma Equity Group A/S
Exploration of options regarding a directed capital increase at market price in Pharma Equity Group A/S
Notice convening the extraordinary general meeting of Pharma Equity Group A/S
Indkaldelse til ekstraordinær generalforsamling i Pharma Equity Group A/S
![Dagens aktienyheder 26/04: Boozt og Pharma Equity Group](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=contain/https://content.inderes.se/assets/ef4363cc-65b2-48d2-8e7b-c6d06f7c2c41.png)
Dagens aktienyheder 26/04: Boozt og Pharma Equity Group
![Pharma Equity Group (One-pager): Continues to move forward but the shares continues to slide](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/e63e4a03-8498-4f91-be79-24be09bcc666.png)